BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3434141)

  • 1. [Whole blood, plasma and erythrocyte internal viscosities in hypergammaglobulinemia: their causal relations with hyperviscosity syndrome].
    Fujioka S
    Nihon Ketsueki Gakkai Zasshi; 1987 Aug; 50(5):1024-30. PubMed ID: 3434141
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum hyperviscosity syndrome associated with IgG myeloma in a cat--.
    Hribernik TN; Barta O; Gaunt SD; Boudreaux MK
    J Am Vet Med Assoc; 1982 Jul; 181(2):169-70. PubMed ID: 7118700
    [No Abstract]   [Full Text] [Related]  

  • 3. Central retinal vein occlusion in two patients with immunoglobulin G multiple myeloma associated with blood hyperviscosity.
    Hayasaka S; Ugomori S; Kodama T; Noda S; Setogawa T
    Ann Ophthalmol; 1993 May; 25(5):191-4. PubMed ID: 8517591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Light chain disease associated with the hyperviscosity syndrome.
    Khan P; Roth MS; Keren DF; Foon KA
    Cancer; 1987 Nov; 60(9):2267-8. PubMed ID: 3125955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of blood hyperviscosity syndrome with continuous plasma exchange using a Fenval CS 3000 separator in patients with multiple myeloma].
    Usnarska-Zubkiewicz L; Gola A
    Pol Tyg Lek; 1993 Feb 1-8; 48(5-6):123-5. PubMed ID: 8361907
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma cell dyscrasias. Part I: Fluorescein angiography findings.
    Avisar R; Shoenfeld Y; Pick AI; Creter D; Cohen A; Djaldetti M; Savir H
    Metab Pediatr Ophthalmol; 1981; 5(3-4):171-5. PubMed ID: 6796791
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hyperviscosity syndrome].
    Hashimoto T
    Nihon Rinsho; 1995 Mar; 53(3):695-8. PubMed ID: 7699907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Plasmapheresis and hyperviscosity syndrome].
    Corral Alonso M; Barbolla ML
    Sangre (Barc); 1984; 29(5):940-50. PubMed ID: 6441295
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experience with plasma exchange: application of an apparatus for plasmapheresis (Haemonetics Model 30) in hyperviscosity syndrome].
    Amamiya Y; Baba M; Hisamitsu J; Ito T; Amaki T
    Rinsho Ketsueki; 1978 Oct; 19(10):1436-8. PubMed ID: 105174
    [No Abstract]   [Full Text] [Related]  

  • 10. Hyperviscosity syndrome in plasma cell dyscrasias.
    Mehta J; Singhal S
    Semin Thromb Hemost; 2003 Oct; 29(5):467-71. PubMed ID: 14631546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperviscosity syndrome in patients with multiple myeloma.
    Mullen E; Mendez N
    Oncol Nurs Forum; 2008 May; 35(3):350-2. PubMed ID: 18467286
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical aspects and therapy of hyperviscosity syndrome. Clinical, viscosimetric and plethysmographic studies on the efficacy and duration of the effects of erythrocytapheresis and plasmapheresis in polycythemia vera and monoclonal gammopathies].
    van den Berg E; Haedicke C; Sgries B; Stangel W; Altmann S; Hartmann F
    Vasa Suppl; 1983; 10():1-37. PubMed ID: 6340361
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hyperviscosity syndrome in plasma cell dyscrasias].
    Somer T
    Duodecim; 1977; 93(9):586-603. PubMed ID: 406132
    [No Abstract]   [Full Text] [Related]  

  • 14. IgG-K-multiple myeloma with hyperviscosity syndrome--response to plasmapheresis.
    Wolf RE; Alperin JB; Ritzmann SE; Levin WC
    Arch Intern Med; 1972 Jan; 129(1):114-7. PubMed ID: 5008038
    [No Abstract]   [Full Text] [Related]  

  • 15. [Myeloma serum hyperviscosity syndrome treated with plasmapheresis].
    Radović M; Durić D; Trajković B; Radojicić B; Pekic B; Tomasević R; Dujić A
    Med Pregl; 1977; 30(9-10):471-6. PubMed ID: 600211
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of plasmapheresis on hyperviscosity-related retinopathy and retinal hemodynamics in patients with Waldenstrom's macroglobulinemia.
    Menke MN; Feke GT; McMeel JW; Treon SP
    Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1157-60. PubMed ID: 18326744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acute confusion syndrome secondary to hyperviscosity in multiple myeloma].
    Gómez E; Roncero C; de Pablo J; Bladé J
    Med Clin (Barc); 1999 Nov; 113(16):635. PubMed ID: 10609259
    [No Abstract]   [Full Text] [Related]  

  • 18. Decreased anion gap associated with monoclonal and pseudomonoclonal gammopathy.
    Frohlich J; Adam W; Golbey MJ; Bernstein M
    Can Med Assoc J; 1976 Feb; 114(3):231-2. PubMed ID: 1032353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hemodilution and plasmapheresis in the therapy of hyperviscosity syndromes].
    Di Lollo F; Fazzini G; Avanzi G
    Ric Clin Lab; 1983; 13 Suppl 3():225-44. PubMed ID: 6424221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of hyperviscosity in monoclonal gammopathies.
    Crawford J; Cox EB; Cohen HJ
    Am J Med; 1985 Jul; 79(1):13-22. PubMed ID: 4014299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.